OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Vaping and CBD: can new technology overcome old problems?	240
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	157
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	117
E-cigarette use in young adults and adolescents: not so safe?	115
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	87
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	85
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline	79
Ablation for lung cancer: hot or cold intervention	78
Lung development genes, adult lung function and cardiovascular comorbidities	75
Correction: British Thoracic Society Winter Meeting 2023	66
Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study	62
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	61
Complex coexistence of COPD and cardiovascular disease	61
What constitutes meaningful gain in skeletal muscle strength in COPD?	61
Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease	59
Ultrafine particles and health: the next frontier in understanding air pollution hazards	58
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	54
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	54
At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation	53
Upstaging of screen-detected lung cancers during diagnostic assessment	43
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	42
British Thoracic Society Guideline for pleural disease	41
Toxic metals and lung health: silent poisons?	41
Muscle memory: genetic factors underlying functional impairment in COPD	40
Beyond detection: what happens after lung cancer screening matters more	39

Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	39
Ageing and ivacaftor: unravelling the long-term effects	38
Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution	38
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	37
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	36
Stretching the diagnosis: tracheobronchomegaly in alpha-1 antitrypsin deficiency or coexisting Mounier-Kuhn syndrome?	35
Delayed presentation of pulmonary Echinococcus in a patient with no major risk factors	35
Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B	33